In 2015, PATH publicly launched the Reach Campaign with the goal of raising $100 million from individuals, family foundations, and corporations to drive the most promising innovations farther and faster. The campaign will target the four areas we believe are most essential to improving the health of vulnerable women and children: malaria, women’s reproductive health, maternal and newborn health, and child health, focusing on the leading killers of children under age five.
PATH’s Global Health Innovation Hub initiative seeks innovation wherever it may occur to accelerate access to health solutions. Starting in India and South Africa, we are supporting an emerging network of scientists, entrepreneurs, companies, and investors focused on health innovation. We are teaming up to evaluate local innovations; support product development, research, and introduction; and link innovators with investment opportunities and global partners. The goal: to scale up technologies and products that will create significant health impact in low-resource communities.
Getting people to change their habits in favor of healthier behaviors is one of the biggest challenges in global health. PATH’s Projecting health project empowers local community members to produce, edit, and star in health education videos customized for local contexts and dialects. With a low-cost, portable projector and a white sheet for a screen, the videos are reaching remote communities in Ethiopia and India with accurate information on breastfeeding, immunization, childbirth, and more. Our data suggest this approach is beginning to change health behaviors.
A new single-size diaphragm offers women a safe, easy-to-use, nonhormonal contraceptive choice. The Caya® contoured diaphragm was developed by PATH and our partners, informed by input from women and health care providers, and has been introduced in more than 15 countries. Recent market clearance by the US Food and Drug Administration—a gold standard of regulatory approval globally—will make the diaphragm available in the United States in 2015 and could pave the way for introduction in developing-country markets.
Caya is a registered trademark of Kessel medintim GmbH.
The PATH-led Innovation Countdown 2030 initiative is reimagining what’s possible in global health. The initiative aims to identify, evaluate, and showcase high-impact technologies and ideas that can transform global health by 2030. By engaging entrepreneurs, investors, innovators, and experts across sectors and around the world, we aim to help drive decision-making and investments in game-changing innovations and accelerate progress toward achieving the United Nations Sustainable Development Goals and related health targets.
PATH’s Innovation Fund grant, supported by the Bill & Melinda Gates Foundation, inspires and supports ideas proposed by PATH staff that could lead to new global health innovations. In 2014, PATH staff proposed 114 ideas, with nine selected for funding. They include a novel water treatment technology to tackle diarrheal disease; an antiretroviral medicine formulation for children that combines HIV treatment with micronutrients to address child malnutrition; and edible insects as a community-based solution to undernutrition that could also create income-generating opportunities for women.